Zhengbin Yao

Insider Reports History

Entity
Individual
Location
10301 Stella Link Road, Houston, TX
Signature
/s/ Sara Klein, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Zhengbin Yao:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ArriVent Biopharma, Inc. President and CEO, Director Common Stock 394K $1.44M $3.65 Jan 25, 2024 Held by The MAKS Yao Trust
ArriVent Biopharma, Inc. President and CEO, Director Common Stock 219K $798K $3.65 Jan 25, 2024 Held by ArriMed BioPharma, LLC
ALUMIS INC. Director Common Stock 23.5K $376K $16.00 Jul 1, 2024 Direct
NexImmune, Inc. Director Stock Option (right to buy) 45K Jul 5, 2023 Direct
ALUMIS INC. Director Stock Option (Right to Buy) 4.28K Jul 1, 2024 Direct
ALUMIS INC. Director Class A Common Stock 0 Jul 1, 2024 Direct

Insider Reports Filed by Zhengbin Yao

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALMS ALUMIS INC. Jun 27, 2024 7 $0 4 Jul 1, 2024 Director
ALMS ALUMIS INC. Jun 27, 2024 0 $0 3 Jun 27, 2024 Director
AVBP ArriVent Biopharma, Inc. Jan 25, 2024 0 $0 3 Jan 25, 2024 President and CEO, Director
NEXI NexImmune, Inc. Jul 5, 2023 1 $0 4 Jul 7, 2023 Director
NEXI NexImmune, Inc. Apr 4, 2023 6 $0 4 Apr 6, 2023 Director
NEXI NexImmune, Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director